SUBSCRIBE

---

Insightful analysis to help you comply with U.S. and international pharmaceutical manufacturing QA/QC requirements.

---

About | Staff | Free Trial | Advertise

“The Gold Sheet” is the biopharma industry’s premier guide to global pharmaceutical QA/QC compliance issues, delivering the most reliable, timely and insightful news and analysis of developments in GMP compliance and quality systems in drug manufacturing, focusing on what the headlines and soundbites actually mean for you and your company.

“The Gold Sheet” helps executives in regulatory affairs and quality control, plus industry attorneys and consultants, improve compliance, reduce costs, understand trends in recalls and warning letters, improve their supply chain, adopt new best practices, avoid disastrous inspection results, and control manufacturing processes.

“The Gold Sheet” offers in-depth, expert monthly coverage that includes:

• Analysis of developments in FDA regulations and policies
• Analysis of regional and global quality requirements, including those of EMA, ICH, WHO, PIC/S, SFDA, Anvisa and more
• State-of-the-art production and quality techniques
• Trends in quality assurance and quality control practices
• Best practices in supply chain integrity
• A vast range of GMP issues, such as sterility, microbial controls, validation, laboratory data integrity, cross contamination, out-of-spec (OOS) results and stability testing
• Drug recall and warning letter data
• Early warning of new directions in enforcement policy
• Insights from peers on ensuring quality from contract suppliers and service providers

Your subscription to “The Gold Sheet” will include:

• 12 monthly print issues
• Online access: Searchable access to a rolling 90 or 365 days of content
• Archives: Available access to the information you need from our complete archive
• Topical RSS Feeds